BC
Bantamac Capital, LLC
13F filer · CIK 0001794972Reported Aug 10, 2026
Net seller this quarter
13F portfolio value$195MU.S. long equity reported on 13F
Positions492 new · 1 closed
Net flow last quarter-$12.4MBuys minus sells
Top 10 positions weight50.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 10, 202649 positions | |||||
| $19.1M | 9.79% | 0.00% | -28.8% | Q4 2021 | |
| $17.2M | 8.81% | 0.07% | -2.6% | Q4 2021 | |
| $17.1M | 8.75% | 0.01% | Not reported | Q2 2022 | |
| $16.9M | 8.66% | 0.00% | -22.3% | Q4 2021 | |
| $6.42M | 3.29% | Not reported | Not reported | Q4 2021 | |
| $5.38M | 2.75% | Not reported | -3.4% | Q4 2021 | |
| $5.02M | 2.57% | 0.01% | Not reported | Q4 2021 | |
| $4.57M | 2.34% | Not reported | +108.9% | Q4 2021 | |
| $3.15M | 1.61% | Not reported | -3.2% | Q4 2021 | |
| $2.73M | 1.40% | 0.00% | -26.1% | Q2 2023 | |
| $2.65M | 1.36% | 0.00% | Not reported | Q4 2021 | |
| $2.02M | 1.04% | 0.00% | Not reported | Q4 2021 | |
| $1.5M | 0.77% | Not reported | Not reported | Q4 2021 | |
| $1.4M | 0.72% | Not reported | -0.6% | Q3 2022 | |
| $1.28M | 0.65% | 0.00% | Not reported | Q4 2021 | |
| $1.25M | 0.64% | Not reported | -19.1% | Q2 2023 | |
| $1.04M | 0.53% | 0.00% | Not reported | Q4 2021 | |
| $951K | 0.49% | 0.00% | Not reported | Q4 2021 | |
| $901K | 0.46% | 0.00% | -2.2% | Q4 2021 | |
| $865K | 0.44% | 0.00% | -6.0% | Q2 2023 | |
| $787K | 0.40% | 0.00% | Not reported | Q2 2022 | |
| $762K | 0.39% | 0.00% | -20.0% | Q4 2021 | |
| $727K | 0.37% | 0.00% | -22.3% | Q4 2021 | |
| $688K | 0.35% | 0.00% | -0.5% | Q4 2021 | |
| $686K | 0.35% | 0.00% | Not reported | Q4 2021 | |
| $659K | 0.34% | 0.00% | -25.4% | Q4 2021 | |
| $635K | 0.33% | 0.00% | Not reported | Q2 2023 | |
| $610K | 0.31% | 0.00% | Not reported | Q4 2021 | |
| $587K | 0.30% | 0.00% | Not reported | Q2 2023 | |
| $569K | 0.29% | 0.00% | Not reported | Q4 2021 | |
| $514K | 0.26% | 0.00% | Not reported | Q4 2021 | |
| $481K | 0.25% | 0.00% | Not reported | Q4 2021 | |
| $470K | 0.24% | 0.00% | Not reported | Q4 2022 | |
| $427K | 0.22% | 0.00% | Not reported | Q4 2021 | |
| $376K | 0.19% | 0.00% | Not reported | Q4 2021 | |
| $367K | 0.19% | 0.00% | Not reported | Q4 2021 | |
| $354K | 0.18% | 0.00% | Not reported | Q4 2021 | |
| $352K | 0.18% | 0.00% | Not reported | Q2 2024 | |
| $309K | 0.16% | 0.00% | Not reported | Q2 2023 | |
| $289K | 0.15% | 0.00% | Not reported | Q2 2023 | |
| $278K | 0.14% | 0.00% | Not reported | Q2 2023 | |
| $272K | 0.14% | 0.00% | Not reported | Q2 2023 | |
| $270K | 0.14% | 0.00% | Not reported | Q3 2022 | |
| $245K | 0.13% | 0.00% | Not reported | Q4 2021 | |
| $244K | 0.12% | 0.00% | +1.6% | Q4 2021 | |
| $236K | 0.12% | 0.00% | Not reported | Q4 2025 | |
| $234K | 0.12% | 0.00% | Not reported | Q4 2021 | |
| $204K | 0.10% | 0.00% | Not reported | Q2 2023 | |
| ETESPREsperion Therapeutics, Inc. | $41.1K | 0.02% | 0.01% | Not reported | Q1 2026 |
| Q1 2026Reported May 11, 202648 positions | |||||
| $23.4M | 12.60% | 0.00% | Not reported | Q4 2021 | |
| $20.5M | 11.00% | 0.07% | -0.1% | Q4 2021 | |
| $19.1M | 10.27% | 0.00% | -0.1% | Q4 2021 | |
| $14.3M | 7.68% | 0.01% | Not reported | Q2 2022 | |
| $6.52M | 3.50% | Not reported | Not reported | Q4 2021 | |
| $4.98M | 2.68% | 0.01% | Not reported | Q4 2021 | |
| $4.85M | 2.61% | Not reported | -5.1% | Q4 2021 | |
| $2.64M | 1.42% | Not reported | Not reported | Q4 2021 | |
| $2.1M | 1.13% | Not reported | -0.5% | Q4 2021 | |
| $2.04M | 1.09% | 0.00% | Not reported | Q4 2021 | |
| $1.44M | 0.77% | Not reported | Not reported | Q4 2021 | |
| $1.35M | 0.72% | 0.00% | Not reported | Q4 2021 | |
| $1.32M | 0.71% | Not reported | -1.1% | Q3 2022 | |
| $1.21M | 0.65% | Not reported | +5.0% | Q2 2023 | |
| $1.18M | 0.63% | 0.00% | Not reported | Q4 2021 | |
| $1.15M | 0.62% | 0.00% | Not reported | Q4 2021 | |
| $1.11M | 0.60% | 0.00% | +29.8% | Q4 2021 | |
| $1.08M | 0.58% | 0.00% | -3.0% | Q2 2023 | |
| $1.04M | 0.56% | 0.00% | Not reported | Q4 2021 | |
| $948K | 0.51% | 0.00% | Not reported | Q4 2021 | |
| $845K | 0.45% | 0.00% | Not reported | Q4 2021 | |
| $802K | 0.43% | 0.00% | +4.6% | Q2 2023 | |
| $796K | 0.43% | 0.00% | Not reported | Q4 2021 | |
| $679K | 0.36% | 0.00% | Not reported | Q2 2022 | |
| $672K | 0.36% | 0.00% | -4.5% | Q4 2021 | |
| $650K | 0.35% | 0.00% | Not reported | Q4 2021 | |
| $587K | 0.32% | 0.00% | Not reported | Q4 2021 | |
| $532K | 0.29% | 0.00% | +9.4% | Q4 2021 | |
| $517K | 0.28% | 0.00% | Not reported | Q2 2023 | |
| $495K | 0.27% | 0.00% | Not reported | Q4 2021 | |
| $482K | 0.26% | 0.00% | Not reported | Q2 2023 | |
| $481K | 0.26% | 0.00% | Not reported | Q4 2021 | |
| $430K | 0.23% | 0.00% | Not reported | Q4 2022 | |
| $409K | 0.22% | 0.00% | +4.0% | Q4 2021 | |
| $396K | 0.21% | 0.00% | Not reported | Q4 2021 | |
| $361K | 0.19% | 0.00% | Not reported | Q4 2021 | |
| $343K | 0.18% | 0.00% | Not reported | Q4 2021 | |
| $329K | 0.18% | 0.00% | Not reported | Q2 2023 | |
| $299K | 0.16% | 0.00% | Not reported | Q4 2021 | |
| $289K | 0.16% | 0.00% | Not reported | Q3 2022 | |
| $281K | 0.15% | 0.00% | Not reported | Q4 2021 | |
| $262K | 0.14% | 0.00% | Not reported | Q2 2024 | |
| $255K | 0.14% | 0.00% | Not reported | Q4 2025 | |
| $242K | 0.13% | 0.00% | Not reported | Q2 2023 | |
| $236K | 0.13% | 0.00% | Not reported | Q2 2023 | |
| $220K | 0.12% | 0.00% | -0.2% | Q4 2021 | |
| $51.4K | 0.03% | 0.08% | New | Q1 2026 | |
| ETESPREsperion Therapeutics, Inc. | $35.6K | 0.02% | 0.01% | New | Q1 2026 |
| Q4 2025Reported Feb 10, 202648 positions | |||||
| $26M | 12.53% | 0.00% | 0.0% | Q4 2021 | |
| $20.5M | 9.87% | 0.00% | -0.7% | Q4 2021 | |
| $18.3M | 8.82% | 0.07% | -5.2% | Q4 2021 | |
| $14.9M | 7.16% | 0.01% | Not reported | Q2 2022 | |
| $7.53M | 3.63% | Not reported | -0.9% | Q4 2021 | |
| $5.36M | 2.58% | Not reported | +1.8% | Q4 2021 | |
| $4.53M | 2.19% | 0.01% | Not reported | Q4 2021 | |
| $2.89M | 1.39% | Not reported | -8.9% | Q4 2021 | |
| $2.38M | 1.15% | 0.00% | -4.3% | Q4 2021 | |
| $2.21M | 1.06% | Not reported | +5.2% | Q4 2021 | |
| $1.51M | 0.73% | Not reported | Not reported | Q4 2021 | |
| $1.35M | 0.65% | 0.00% | Not reported | Q4 2021 | |
| $1.29M | 0.62% | Not reported | -24.2% | Q3 2022 | |
| $1.26M | 0.61% | 0.00% | +105.3% | Q4 2021 | |
| $1.23M | 0.59% | Not reported | Not reported | Q2 2023 | |
| $1.22M | 0.59% | 0.00% | Not reported | Q4 2021 | |
| $1.14M | 0.55% | 0.00% | +66.5% | Q4 2021 | |
| $1.09M | 0.53% | 0.00% | +33.3% | Q4 2021 | |
| $1.09M | 0.52% | 0.00% | Not reported | Q4 2021 | |
| $942K | 0.45% | 0.00% | -17.5% | Q2 2023 | |
| $836K | 0.40% | 0.00% | -3.7% | Q4 2021 | |
| $829K | 0.40% | 0.00% | Not reported | Q2 2022 | |
| $821K | 0.40% | 0.00% | -4.4% | Q2 2023 | |
| $698K | 0.34% | 0.00% | Not reported | Q4 2021 | |
| $655K | 0.32% | 0.00% | -4.8% | Q4 2021 | |
| $600K | 0.29% | 0.00% | Not reported | Q2 2023 | |
| $583K | 0.28% | 0.00% | Not reported | Q4 2021 | |
| $535K | 0.26% | 0.00% | Not reported | Q4 2021 | |
| $524K | 0.25% | 0.00% | Not reported | Q2 2023 | |
| $497K | 0.24% | 0.00% | Not reported | Q4 2021 | |
| $468K | 0.23% | 0.00% | Not reported | Q4 2021 | |
| $447K | 0.22% | 0.00% | Not reported | Q4 2021 | |
| $417K | 0.20% | 0.00% | Not reported | Q4 2022 | |
| $401K | 0.19% | 0.00% | Not reported | Q4 2021 | |
| $361K | 0.17% | 0.05% | +9.0% | Q4 2021 | |
| $358K | 0.17% | 0.00% | Not reported | Q4 2021 | |
| $346K | 0.17% | 0.00% | Not reported | Q4 2021 | |
| $337K | 0.16% | 0.00% | Not reported | Q4 2021 | |
| $308K | 0.15% | 0.00% | Not reported | Q4 2021 | |
| $295K | 0.14% | 0.00% | Not reported | Q3 2022 | |
| $291K | 0.14% | 0.00% | New | Q4 2025 | |
| $285K | 0.14% | 0.00% | +1.5% | Q2 2023 | |
| $259K | 0.13% | 0.00% | Not reported | Q4 2021 | |
| $245K | 0.12% | 0.00% | Not reported | Q2 2023 | |
| $224K | 0.11% | 0.00% | Not reported | Q2 2023 | |
| $222K | 0.11% | 0.00% | Not reported | Q4 2021 | |
| $204K | 0.10% | 0.00% | Not reported | Q4 2024 | |
| $200K | 0.10% | 0.00% | Not reported | Q4 2021 | |
| Q3 2025Reported Nov 10, 202544 positions | |||||
| $24.7M | 12.70% | 0.00% | -8.9% | Q4 2021 | |
| $19.3M | 9.92% | 0.00% | -2.2% | Q4 2021 | |
| $18.9M | 9.69% | 0.07% | -0.2% | Q4 2021 | |
| $13.5M | 6.91% | 0.01% | -0.2% | Q2 2022 | |
| $8.45M | 4.34% | Not reported | -2.9% | Q4 2021 | |
| $5.14M | 2.64% | Not reported | +2.0% | Q4 2021 | |
| $4.93M | 2.53% | 0.01% | Not reported | Q4 2021 | |
| $2.46M | 1.26% | Not reported | -6.0% | Q4 2021 | |
| $2.1M | 1.08% | Not reported | 0.0% | Q4 2021 | |
| $1.76M | 0.91% | 0.00% | -5.6% | Q4 2021 | |
| $1.67M | 0.86% | Not reported | -52.8% | Q3 2022 | |
| $1.51M | 0.77% | Not reported | Not reported | Q4 2021 | |
| $1.45M | 0.74% | 0.00% | -20.3% | Q4 2021 | |
| $1.09M | 0.56% | 0.00% | -2.9% | Q4 2021 | |
| $907K | 0.47% | 0.00% | Not reported | Q4 2021 | |
| $880K | 0.45% | 0.00% | -3.0% | Q4 2021 | |
| $858K | 0.44% | 0.00% | -80.3% | Q2 2023 | |
| $811K | 0.42% | 0.00% | +3.8% | Q4 2021 | |
| $790K | 0.41% | 0.00% | Not reported | Q2 2022 | |
| $686K | 0.35% | 0.00% | -2.6% | Q4 2021 | |
| $669K | 0.34% | 0.00% | Not reported | Q2 2023 | |
| $599K | 0.31% | 0.00% | Not reported | Q4 2021 | |
| $595K | 0.31% | 0.00% | Not reported | Q4 2021 | |
| $593K | 0.30% | 0.00% | -4.6% | Q4 2021 | |
| $584K | 0.30% | 0.00% | -12.2% | Q2 2023 | |
| $583K | 0.30% | 0.00% | Not reported | Q4 2021 | |
| $555K | 0.28% | 0.00% | Not reported | Q4 2021 | |
| $511K | 0.26% | 0.00% | Not reported | Q2 2023 | |
| $495K | 0.25% | 0.00% | Not reported | Q4 2021 | |
| $445K | 0.23% | 0.00% | 0.0% | Q4 2021 | |
| $440K | 0.23% | 0.00% | Not reported | Q4 2021 | |
| $424K | 0.22% | 0.00% | Not reported | Q4 2021 | |
| $422K | 0.22% | 0.00% | Not reported | Q4 2022 | |
| $384K | 0.20% | 0.00% | Not reported | Q4 2021 | |
| $341K | 0.18% | 0.00% | Not reported | Q4 2021 | |
| $338K | 0.17% | 0.00% | Not reported | Q4 2021 | |
| $326K | 0.17% | 0.05% | Not reported | Q4 2021 | |
| $320K | 0.16% | 0.00% | Not reported | Q4 2021 | |
| $308K | 0.16% | 0.00% | Not reported | Q3 2022 | |
| $301K | 0.15% | 0.00% | -23.5% | Q2 2023 | |
| $254K | 0.13% | 0.00% | -9.2% | Q4 2021 | |
| $237K | 0.12% | 0.00% | Not reported | Q2 2023 | |
| $214K | 0.11% | 0.00% | Not reported | Q4 2021 | |
| $206K | 0.11% | 0.00% | Not reported | Q4 2024 | |
Premium opens every quarter this fund has filed